125 related articles for article (PubMed ID: 1537074)
61. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
Cheng G; Li Y; Tian F
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
[TBL] [Abstract][Full Text] [Related]
62. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
Chiang CD; Song EJ; Yang VC; Chao CC
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
[TBL] [Abstract][Full Text] [Related]
63. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs.
Walther W; Stein U
J Cancer Res Clin Oncol; 1994; 120(8):471-8. PubMed ID: 8207045
[TBL] [Abstract][Full Text] [Related]
64. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
65. A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene.
Narasaki F; Oka M; Fukuda M; Nakano R; Ikeda K; Takatani H; Terashi K; Soda H; Yano O; Nakamura T; Doyle LA; Tsuruo T; Kohno S
Cancer Chemother Pharmacol; 1997; 40(5):425-32. PubMed ID: 9272120
[TBL] [Abstract][Full Text] [Related]
66. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
67. Expression of the MDR1 gene in human gastric and colorectal carcinomas.
Mizoguchi T; Yamada K; Furukawa T; Hidaka K; Hisatsugu T; Shimazu H; Tsuruo T; Sumizawa T; Akiyama S
J Natl Cancer Inst; 1990 Nov; 82(21):1679-83. PubMed ID: 1977924
[TBL] [Abstract][Full Text] [Related]
68. [Effect of quercetin on doxorubicin-induced expression of MDR1 gene in HL-60 cells].
He HL; Ji LJ; Li QZ; Zhang R; Huang JM; Li G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):70-6. PubMed ID: 25687049
[TBL] [Abstract][Full Text] [Related]
69. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair.
Chao CC
Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556
[TBL] [Abstract][Full Text] [Related]
70. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
71. Doxorubicin, vincristine, and actinomycin-D, but not teniposide, require long-lasting uninterrupted verapamil pressure to overcome drug resistance in multidrug-resistant cells.
Toffoli G; Tumiotto L; Gigante M; Perin T; Biscontin G; Boiocchi M
Cancer Detect Prev; 1993; 17(3):425-32. PubMed ID: 8402730
[TBL] [Abstract][Full Text] [Related]
72. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
[TBL] [Abstract][Full Text] [Related]
73. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
Lopes EC; Scolnik M; Alvarez E; Hajos SE
Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565
[TBL] [Abstract][Full Text] [Related]
74. Expression of the multidrug resistance, MDR1, gene in neuroblastomas.
Goldstein LJ; Fojo AT; Ueda K; Crist W; Green A; Brodeur G; Pastan I; Gottesman MM
J Clin Oncol; 1990 Jan; 8(1):128-36. PubMed ID: 2295903
[TBL] [Abstract][Full Text] [Related]
75. Establishment of new multidrug-resistant human osteosarcoma cell lines.
Oda Y; Matsumoto Y; Harimaya K; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2000; 7(4):859-66. PubMed ID: 10854558
[TBL] [Abstract][Full Text] [Related]
76. Tumor escape mechanism involving Fas and Fas-L molecules in human colorectal tumors.
Radfar S; Martin H; Tilkin-Mariame AF
Gastroenterol Clin Biol; 2000 Dec; 24(12):1191-6. PubMed ID: 11173732
[TBL] [Abstract][Full Text] [Related]
77. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein.
Ueda K; Cornwell MM; Gottesman MM; Pastan I; Roninson IB; Ling V; Riordan JR
Biochem Biophys Res Commun; 1986 Dec; 141(3):956-62. PubMed ID: 2880583
[TBL] [Abstract][Full Text] [Related]
78. Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay.
Clifford SC; Thomas DJ; Neal DE; Lunec J
Br J Cancer; 1994 Apr; 69(4):680-6. PubMed ID: 7908215
[TBL] [Abstract][Full Text] [Related]
79. Constitutive expression of multidrug resistance in human colorectal tumours and cell lines.
Kramer R; Weber TK; Morse B; Arceci R; Staniunas R; Steele G; Summerhayes IC
Br J Cancer; 1993 May; 67(5):959-68. PubMed ID: 8098614
[TBL] [Abstract][Full Text] [Related]
80. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene.
Fojo AT; Shen DW; Mickley LA; Pastan I; Gottesman MM
J Clin Oncol; 1987 Dec; 5(12):1922-7. PubMed ID: 3681376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
